
### [NCIT:C3411](http://purl.obolibrary.org/obo/NCIT_C3411)
**Label:** Thymoma

**Subclasses:** [NCIT:C7904](http://purl.obolibrary.org/obo/NCIT_C7904) (Invasive Malignant Thymoma), [NCIT:C6453](http://purl.obolibrary.org/obo/NCIT_C6453) (Invasive Thymoma), [NCIT:C136350](http://purl.obolibrary.org/obo/NCIT_C136350) (Stage III Thymoma AJCC v8), [NCIT:C95048](http://purl.obolibrary.org/obo/NCIT_C95048) (Ectopic Cervical Thymoma), [NCIT:C6454](http://purl.obolibrary.org/obo/NCIT_C6454) (Thymoma Type A), [NCIT:C136353](http://purl.obolibrary.org/obo/NCIT_C136353) (Stage IV Thymoma AJCC v8), [NCIT:C7386](http://purl.obolibrary.org/obo/NCIT_C7386) (Encapsulated Thymoma), [NCIT:C45707](http://purl.obolibrary.org/obo/NCIT_C45707) (Metaplastic Thymoma), [NCIT:C45709](http://purl.obolibrary.org/obo/NCIT_C45709) (Sclerosing Thymoma), [NCIT:C7905](http://purl.obolibrary.org/obo/NCIT_C7905) (Recurrent Malignant Thymoma), [NCIT:C6889](http://purl.obolibrary.org/obo/NCIT_C6889) (Malignant Type B2 Thymoma), [NCIT:C136345](http://purl.obolibrary.org/obo/NCIT_C136345) (Thymoma by AJCC v8 Stage), [NCIT:C7612](http://purl.obolibrary.org/obo/NCIT_C7612) (Malignant Thymoma), [NCIT:C7997](http://purl.obolibrary.org/obo/NCIT_C7997) (Thymoma Type B3), [NCIT:C6886](http://purl.obolibrary.org/obo/NCIT_C6886) (Malignant Type AB Thymoma), [NCIT:C7996](http://purl.obolibrary.org/obo/NCIT_C7996) (Malignant Type B1 Thymoma), [NCIT:C6885](http://purl.obolibrary.org/obo/NCIT_C6885) (Thymoma Type AB), [NCIT:C136349](http://purl.obolibrary.org/obo/NCIT_C136349) (Stage II Thymoma AJCC v8), [NCIT:C7999](http://purl.obolibrary.org/obo/NCIT_C7999) (Malignant Type A Thymoma), [NCIT:C6888](http://purl.obolibrary.org/obo/NCIT_C6888) (Thymoma Type B2), [NCIT:C136348](http://purl.obolibrary.org/obo/NCIT_C136348) (Stage I Thymoma AJCC v8), [NCIT:C6887](http://purl.obolibrary.org/obo/NCIT_C6887) (Thymoma Type B1), [NCIT:C7114](http://purl.obolibrary.org/obo/NCIT_C7114) (Thymoma Type B), [NCIT:C45638](http://purl.obolibrary.org/obo/NCIT_C45638) (Intrapulmonary Thymoma), [NCIT:C45639](http://purl.obolibrary.org/obo/NCIT_C45639) (Mediastinal Thymoma), [NCIT:C9080](http://purl.obolibrary.org/obo/NCIT_C9080) (Noninvasive Malignant Thymoma), 

**Class expressions from DL-Learner:**

- [UBERON:0003846](http://purl.obolibrary.org/obo/UBERON_0003846) (thymus epithelium) 55.56%
- Thing 52.40%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38176](http://purl.obolibrary.org/obo/NCIT_C38176) (BCL2 Gene Translocation))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38175](http://purl.obolibrary.org/obo/NCIT_C38175) (CD44 Messenger RNA Overexpression))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38174](http://purl.obolibrary.org/obo/NCIT_C38174) (IRF4/MUM1 Messenger RNA Overexpression))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38173](http://purl.obolibrary.org/obo/NCIT_C38173) (BCL2 Gene mRNA Overexpression))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38172](http://purl.obolibrary.org/obo/NCIT_C38172) (Cyclin D2 Messenger RNA Overexpression))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38171](http://purl.obolibrary.org/obo/NCIT_C38171) (PKCbeta1 Messenger RNA Overexpression))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38170](http://purl.obolibrary.org/obo/NCIT_C38170) (LMO2 Messenger RNA Overexpression))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38169](http://purl.obolibrary.org/obo/NCIT_C38169) (A-myb Messenger RNA Overexpression))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38168](http://purl.obolibrary.org/obo/NCIT_C38168) (BCL-6 Messenger RNA Overexpression))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38167](http://purl.obolibrary.org/obo/NCIT_C38167) (CD10 Messenger RNA Overexpression))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38158](http://purl.obolibrary.org/obo/NCIT_C38158) (Metachronous Wilms Tumor))) 40.91%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38157](http://purl.obolibrary.org/obo/NCIT_C38157) (Metachronous Osteosarcoma))) 40.91%


